Vasculitis refers to a group of disorders that cause inflammation in your blood vessels. It’s also called angiitis or arteritis. It can cause your blood vessels to become weak, dilated, enlarged, or constricted. Damage to organs and tissues may occur if blood flow is restricted.
Vasculitis has several subtypes, most of which are infrequent. One or more organs may be impacted by vasculitis. Long-term or transient conditions are also possible. Although vasculitis may affect anyone, some forms are more prevalent in particular age groups. The majority of subtypes need medicine to reduce inflammation and minimize flare-ups.
It is unclear what causes vasculitis exactly. Several subtypes are influenced by genetics. Others happen when the immune system unintentionally attacks blood vessel cells. Possible triggers for this immune system reaction include:
The majority of vasculitis types often manifest the following common signs and symptoms:
In accordance with the body parts affected, other signs and symptoms include:
Tests and procedures include –
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.
2.
Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.
3.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
4.
Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma
5.
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
1.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
2.
How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?
3.
Blood Donation Sustainability Through Behavioral Science
4.
Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025
5.
Essential Developments in Oncology for Healthcare Excellence
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation